These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 24696602)

  • 21. Neurotensin receptor 1 overexpression in inflammatory bowel diseases and colitis-associated neoplasia.
    Gui X; Liu S; Yan Y; Gao Z
    World J Gastroenterol; 2013 Jul; 19(28):4504-10. PubMed ID: 23901225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. European consensus on the histopathology of inflammatory bowel disease.
    Magro F; Langner C; Driessen A; Ensari A; Geboes K; Mantzaris GJ; Villanacci V; Becheanu G; Borralho Nunes P; Cathomas G; Fries W; Jouret-Mourin A; Mescoli C; de Petris G; Rubio CA; Shepherd NA; Vieth M; Eliakim R; ;
    J Crohns Colitis; 2013 Nov; 7(10):827-51. PubMed ID: 23870728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic inflammatory bowel disease and cancer.
    Pohl C; Hombach A; Kruis W
    Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
    Dyson JK; Rutter MD
    World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic interobserver variability in Crohn's disease- and ulcerative colitis-associated dysplasia: a multicenter digital survey from the IG-IBD Pathologists Group.
    Leoncini G; Donato F; Reggiani-Bonetti L; Salviato T; Cadei M; Daperno M; Principi MB; Armuzzi A; Caprioli F; Canavese G; Villanacci V;
    Tech Coloproctol; 2021 Jan; 25(1):101-108. PubMed ID: 33025294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colorectal cancer in inflammatory bowel disease: review of the evidence.
    Keller DS; Windsor A; Cohen R; Chand M
    Tech Coloproctol; 2019 Jan; 23(1):3-13. PubMed ID: 30701345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases.
    Itzkowitz SH; Harpaz N
    Gastroenterology; 2004 May; 126(6):1634-48. PubMed ID: 15168373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Aneuploidy and Flat Dysplasia With Development of High-Grade Dysplasia or Colorectal Cancer in Patients With Inflammatory Bowel Disease.
    Tsai JH; Rabinovitch PS; Huang D; Small T; Mattis AN; Kakar S; Choi WT
    Gastroenterology; 2017 Dec; 153(6):1492-1495.e4. PubMed ID: 28843957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colonoscopy surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel disease.
    Aalykke C; Jensen MD; Fallingborg J; Jess T; Langholz E; Meisner S; Andersen NN; Riis LB; Thomsen OØ; Tøttrup A
    Dan Med J; 2015 Jan; 62(1):B4995. PubMed ID: 25557336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of "indefinite for dysplasia" in inflammatory bowel disease: correlation with DNA flow cytometry and other risk factors of colorectal cancer.
    Choi WT; Rabinovitch PS; Wang D; Westerhoff M
    Hum Pathol; 2015 Jul; 46(7):939-47. PubMed ID: 25962315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IBD-Associated Dysplastic Lesions Show More Chromosomal Instability Than Sporadic Adenomas.
    Wanders LK; Cordes M; Voorham Q; Sie D; de Vries SD; d'Haens GRAM; de Boer NKH; Ylstra B; van Grieken NCT; Meijer GA; Dekker E; Carvalho B
    Inflamm Bowel Dis; 2020 Jan; 26(2):167-180. PubMed ID: 31372648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.
    Shah SC; Ten Hove JR; Castaneda D; Palmela C; Mooiweer E; Colombel JF; Harpaz N; Ullman TA; van Bodegraven AA; Jansen JM; Mahmmod N; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; Oldenburg B; Itzkowitz SH; Torres J
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1106-1113.e3. PubMed ID: 29378311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interval Colorectal Cancer in Inflammatory Bowel Disease: A Review.
    Da Cunha T; Vaziri H
    J Clin Gastroenterol; 2024 Jan; 58(1):1-11. PubMed ID: 37548445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colorectal cancer in inflammatory bowel disease: a shift in risk?
    Gallinger ZR; Weizman AV
    Expert Rev Anticancer Ther; 2014 Jul; 14(7):847-56. PubMed ID: 24621115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysplasia in inflammatory bowel diseases.
    Mescoli C; Albertoni L; D'incá R; Rugge M
    Dig Liver Dis; 2013 Mar; 45(3):186-94. PubMed ID: 22974564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromoendoscopy for Surveillance in Inflammatory Bowel Disease Does Not Increase Neoplasia Detection Compared With Conventional Colonoscopy With Random Biopsies: Results From a Large Retrospective Study.
    Mooiweer E; van der Meulen-de Jong AE; Ponsioen CY; Fidder HH; Siersema PD; Dekker E; Oldenburg B
    Am J Gastroenterol; 2015 Jul; 110(7):1014-21. PubMed ID: 25823770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cancer "fear" in IBD patients: is it still REAL?
    Connelly TM; Koltun WA
    J Gastrointest Surg; 2014 Jan; 18(1):213-8. PubMed ID: 24002760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey.
    Baars JE; Kuipers EJ; van Haastert M; Nicolaï JJ; Poen AC; van der Woude CJ
    J Gastroenterol; 2012 Dec; 47(12):1308-22. PubMed ID: 22627504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
    J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The histological diagnosis of dysplastic and neoplastic lesions in inflammatory bowel disease: a pathological perspective.
    Usaj S; Tarabar D; Cuk V; Cerovic S; Brajukovic G; Panisic M; Klem I; Eric Z
    Acta Chir Iugosl; 2004; 51(2):109-16. PubMed ID: 15771301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.